Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune … – Nature.com

Fahn, S. The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future. Parkinsonism Relat. Disord. 46, S1S5 (2018).

Article PubMed Google Scholar

Kalia, L. V. & Lang, A. E. Parkinsons disease. Lancet 386, 896912 (2015).

Article CAS PubMed Google Scholar

Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primers 3, 17013 (2017).

Article PubMed Google Scholar

Obeso, J. A. et al. Missing pieces in the Parkinsons disease puzzle. Nat. Med. 16, 653661 (2010).

Article CAS PubMed Google Scholar

Meissner, W. G. et al. Priorities in Parkinsons disease research. Nat. Rev. Drug Discov. 10, 377393 (2011).

Article CAS PubMed Google Scholar

Barker, R. A., Barrett, J., Mason, S. L. & Bjorklund, A. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinsons disease. Lancet Neurol. 12, 8491 (2013).

Article CAS PubMed Google Scholar

Sonntag, K. C. et al. Pluripotent stem cell-based therapy for Parkinsons disease: Current status and future prospects. Prog. Neurobiol. 168, 120 (2018).

Article PubMed PubMed Central Google Scholar

Parmar, M., Grealish, S. & Henchcliffe, C. The future of stem cell therapies for Parkinson disease. Nat. Rev. Neurosci. 21, 103115 (2020).

Article CAS PubMed Google Scholar

Barker, R. A., Drouin-Ouellet, J. & Parmar, M. Cell-based therapies for Parkinson disease-past insights and future potential. Nat. Rev. Neurol. 11, 492503 (2015).

Article CAS PubMed Google Scholar

Skidmore, S. & Barker, R. A. Challenges in the clinical advancement of cell therapies for Parkinsons disease. Nat. Biomed. Eng. 7, 370386 (2023).

Article PubMed PubMed Central Google Scholar

Cha, Y., Park, T. Y., Leblanc, P. & Kim, K. S. Current status and future perspectives on stem cell-based therapies for Parkinsons disease. J. Mov. Disord. 16, 2241 (2023).

Article PubMed PubMed Central Google Scholar

Lindvall, O. Clinical translation of stem cell transplantation in Parkinsons disease. J. Intern. Med. 279, 3040 (2016).

Article CAS PubMed Google Scholar

Li, J. Y. & Li, W. Postmortem studies of fetal grafts in Parkinsons Disease: What lessons have we learned? Front. Cell. Dev. Biol. 9, 666675 (2021).

Article PubMed PubMed Central Google Scholar

Lindvall, O. et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinsons disease. Science 247, 574577 (1990).

Article CAS PubMed Google Scholar

Defer, G. L. et al. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 119, 4150 (1996).

Article PubMed Google Scholar

Mendez, I. et al. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J. Neurosurg. 96, 589596 (2002).

Article PubMed Google Scholar

Peschanski, M. et al. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinsons disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117, 487499 (1994).

Article PubMed Google Scholar

Freed, C. R. et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinsons disease. N. Engl. J. Med. 327, 15491555 (1992).

Article CAS PubMed Google Scholar

Freeman, T. B. et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinsons disease. Ann. Neurol. 38, 379388 (1995).

Article CAS PubMed Google Scholar

Hagell, P. et al. Sequential bilateral transplantation in Parkinsons disease: Effects of the second graft. Brain 122, 11211132 (1999).

Article PubMed Google Scholar

Kefalopoulou, Z. et al. Long-term clinical outcome of fetal cell transplantation for Parkinson disease: Two case reports. JAMA Neurol. 71, 8387 (2014).

Article PubMed PubMed Central Google Scholar

Kordower, J. H. et al. Functional fetal nigral grafts in a patient with Parkinsons disease: chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370, 203230 (1996).

Article CAS PubMed Google Scholar

Kordower, J. H. et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinsons disease. Mov. Disord. 13, 383393 (1998).

Article CAS PubMed Google Scholar

Lindvall, O. et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinsons disease. A detailed account of methodology and a 6-month follow-up. Arch. Neurol. 46, 615631 (1989).

Article CAS PubMed Google Scholar

Lindvall, O. et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinsons disease. Ann. Neurol. 35, 172180 (1994).

Article CAS PubMed Google Scholar

Lindvall, O. et al. Transplantation of fetal dopamine neurons in Parkinsons disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31, 155165 (1992).

Article CAS PubMed Google Scholar

Mendez, I. et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinsons disease. Brain 128, 14981510 (2005).

Article PubMed Google Scholar

Piccini, P. et al. Dopamine release from nigral transplants visualized in vivo in a Parkinsons patient. Nat. Neurosci. 2, 11371140 (1999).

Article CAS PubMed Google Scholar

Spencer, D. D. et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinsons disease. N. Engl. J. Med. 327, 15411548 (1992).

Article CAS PubMed Google Scholar

Wenning, G. K. et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinsons disease. Ann. Neurol. 42, 95107 (1997).

Article CAS PubMed Google Scholar

Widner, H. et al. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 327, 15561563 (1992).

Article CAS PubMed Google Scholar

Li, W. et al. Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain. Proc. Natl. Acad. Sci. USA 113, 65446549 (2016).

Article CAS PubMed PubMed Central Google Scholar

Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B. & Olanow, C. W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinsons disease. Nat. Med. 14, 504506 (2008).

Article CAS PubMed Google Scholar

Li, J. Y. et al. Lewy bodies in grafted neurons in subjects with Parkinsons disease suggest host-to-graft disease propagation. Nat. Med. 14, 501503 (2008).

Article CAS PubMed Google Scholar

Mendez, I. et al. Dopamine neurons implanted into people with Parkinsons disease survive without pathology for 14 years. Nat. Med. 14, 507509 (2008).

Article CAS PubMed PubMed Central Google Scholar

Greene, P. E. et al. Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease. NPJ Parkinsons Dis. 7, 38 (2021).

Article CAS PubMed PubMed Central Google Scholar

Freed, C. R. et al. Transplantation of embryonic dopamine neurons for severe Parkinsons disease. N. Engl. J. Med. 344, 710719 (2001).

Article CAS PubMed Google Scholar

Olanow, C. W. et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinsons disease. Ann. Neurol. 54, 403414 (2003).

Article PubMed Google Scholar

Thompson, L. & Bjorklund, A. Survival, differentiation, and connectivity of ventral mesencephalic dopamine neurons following transplantation. Prog. Brain Res. 200, 6195 (2012).

Article PubMed Google Scholar

Ramachandran, A. C., Bartlett, L. E. & Mendez, I. M. A multiple target neural transplantation strategy for Parkinsons disease. Rev. Neurosci. 13, 243256 (2002).

Article PubMed Google Scholar

Castilho, R. F., Hansson, O. & Brundin, P. Improving the survival of grafted embryonic dopamine neurons in rodent models of Parkinsons disease. Prog. Brain Res. 127, 203231 (2000).

Article CAS PubMed Google Scholar

Bjorklund, A. & Kordower, J. H. Cell therapy for Parkinsons disease: what next? Mov. Disord. 28, 110115 (2013).

Article CAS PubMed Google Scholar

Brundin, P. et al. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transpl. 9, 179195 (2000).

Article CAS Google Scholar

Brundin, P. et al. Human fetal dopamine neurons grafted in a rat model of Parkinsons disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain Res. 70, 192208 (1988).

Article CAS PubMed Google Scholar

Frodl, E. M., Duan, W. M., Sauer, H., Kupsch, A. & Brundin, P. Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res. 647, 286298 (1994).

Article CAS PubMed Google Scholar

Barker, R. A., Dunnett, S. B., Faissner, A. & Fawcett, J. W. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp. Neurol. 141, 7993 (1996).

Article CAS PubMed Google Scholar

Duan, W. M., Widner, H. & Brundin, P. Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats. Exp. Brain Res. 104, 227242 (1995).

Article CAS PubMed Google Scholar

Emgard, M., Karlsson, J., Hansson, O. & Brundin, P. Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts. Exp. Neurol. 160, 279288 (1999).

Article CAS PubMed Google Scholar

Wenker, S. D. & Pitossi, F. J. Cell therapy for Parkinsons disease is coming of age: current challenges and future prospects with a focus on immunomodulation. Gene Ther. 27, 614 (2020).

Article CAS PubMed Google Scholar

Zawada, W. M. et al. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786, 96103 (1998).

Article CAS PubMed Google Scholar

Read this article:
Past, present, and future of cell replacement therapy for parkinson's disease: a novel emphasis on host immune ... - Nature.com